Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
IP Group unveils maiden dividend after bumper results
Developer of intellectual property-based ventures IP Group (IPO) is trading at its highest level since 2018, rewarding our positive call on the stock in October 2020.
The latest run for the shares followed a strong set of full-year results (10 Mar). The company even unveiled a maiden dividend after swinging to an annual profit as portfolio gains boosted net asset value.
Jefferies notes IP Group’s 15% stake in its main holding, biotech Oxford Nanopore, is being valued ‘well short’ of the investment bank’s estimated $5.4 billion valuation for the company.
IP Group’s net assets increased 16% to £1.3 billion or 125.3p per share during 2020 and it saw record cash realisations of £191 million from its investments.
The company is to seek approval to undertake share buybacks should the shares trade below net asset value per share.
Numis analyst Stefan Hamill commented: ‘Two new unicorns emerged in the portfolio, Ceres Power (CWR:AIM) and Hinge Health, validating IP Group’s ability to identify and build winners beyond Oxford Nanopore.’
SHARES SAYS: Still a buy.